2.825

0.88% -0.025

Scinai Immunotherapeutics Ltd Adr (SCNI)

Overview News Price History Discussions Forecast Stock Split

Scinai Immunotherapeutics Ltd Adr stock is traded at $2.825, with a volume of 7,054. It is down -0.88% in the last 24 hours and down -23.85% over the past month. Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

Previous Close:

$2.85

Open:

$2.925

24h Volume:

7,054

Relative Volume:

0.26

Market Cap:

$2.43M

Revenue:

Net Income/Loss:

$-9.29M

P/E Ratio:

-0.9314

EPS:

-3.0332

Net Cash Flow:

$-9.42M

1W Performance:

-9.16%

1M Performance:

-23.85%

6M Performance:

-37.22%

1Y Performance:

-55.16%

1-Day Range:

$2.75

$2.925

1-Week Range:

$2.75

$3.5733

52-Week Range:

$2.23

$8.92

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Name

Scinai Immunotherapeutics Ltd Adr

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

972-8-9302529

Address

JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM

Employee

Twitter

Next Earnings Date

Latest SEC Filings

SCNI's Discussions on Twitter

Compare SCNI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCNI	2.801	2.43M	0	-9.29M	-9.42M	-3.0332
VRTX	467.34	119.83B	10.63B	-479.80M	-1.35B	13.33
REGN	760.66	83.28B	13.85B	4.65B	3.32B	35.06
ARGX	566.22	33.74B	1.86B	-40.29M	-1.28B	-4.16
ALNY	230.69	30.38B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.41	24.08B	3.30B	-501.07M	1.03B	11.54

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News

Aug 29, 2024

Scinai Regains Full Compliance with Nasdaq Listing Requirements - Benzinga

Aug 29, 2024

Aug 21, 2024

Scinai secures $2 million investment commitment By Investing.com - Investing.com India

Aug 21, 2024

Jul 17, 2024

Today's Market - InvestorPlace

Jul 17, 2024

Taking on analysts’ expectations and winning: Scinai Immunotherapeutics Ltd ADR (SCNI) - SETE News

Jul 17, 2024

Jul 15, 2024

Scinai reports promising psoriasis treatment study - Investing.com

Jul 15, 2024

Heather Campe, Sr. VP at Fuller H B Co, sells shares worth over $1.9m By Investing.com - Investing.com

Jul 15, 2024

Scinai Immunotherapeutics Ltd ADR Inc. (SCNI) Price Performance: The Role of Supply and Demand - The InvestChronicle

Jul 15, 2024

Scinai reports promising psoriasis treatment study By Investing.com - Investing.com

Jul 15, 2024

Jul 03, 2024

Baird lowers Lululemon shares target on mixed U.S. traffic and spending By Investing.com - Investing.com India

Jul 03, 2024

Scinai Immunotherapeutics gets Nasdaq compliance extension By Investing.com - Investing.com

Jul 03, 2024

Jul 02, 2024

ZUU Co. Ltd. executives purchase Pono Capital two shares worth $390 By Investing.com - Investing.com

Jul 02, 2024